NFE2L2 and Nephropathy: In vitro and in vivo studies have demonstrated that sulforaphane ameliorated nephropathy in diabetic rats by activating the Keap1/Nrf2 signaling pathway, an effect that was abolished by siRNA silencing of Nrf2 in cultured tubular cells [198].